A Prospective, parallel arm randomized clinical study to evaluate safety and efficacy of HFSM-02 in reducing stress and anxiety in subjects with chronic medical condition and perceived stress - NI

Siddhayu Ayurvedic Research Fdn Pvt Ltd0 个研究点目标入组 120 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Subjects of age between 18 and 60 years
•Free of psychiatric conditions other than stress
•Have a score less than 15 on the World Health Organizationâ??five (WHO-5) well-being index and a score of at least 14 on the Perceived Stress Scale (PSS)
•CHD patients showing one or more of the following conditions like hypertension, dyslipidemia, atherosclerotic, ischemic changes, with certain psychological stress-related complaints mainly irritation, anxiety, etc. on stable medical prescriptions.
•Prediagnosed diabetes type 2 patients with HbA1c including but NMT 7.5 with certain psychological stress-related complaints mainly irritation, anxiety, etc. and on stable medical prescription

•Subjects suffering from any chronic physical, neurological or psychiatric illness
•Subjects currently undergoing active MI episode
•Subjects with uncontrolled diabetes
•Subjects with compromised liver or renal function test as per sole discretion of investigator that can prove the subject unfit for the trial
•Subjects currently taking any herbal preparations or formulations containing Ashwagandha, ginseng, ginkgo biloba, Brahmi or related herbs,
•Subjects pregnant or lactating
•Subjects with substance dependence
•Subjects in investigators opinion not fit for the study.

发起方

Siddhayu Ayurvedic Research Fdn Pvt Ltd